Literature DB >> 22019759

Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits.

Jing Rui1, Mahrokh Dadsetan, M Brett Runge, Robert J Spinner, Michael J Yaszemski, Anthony J Windebank, Huan Wang.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic stimulator. Controlled release of such stimulators may enhance and guide the vascularization process, and when applied in a nerve conduit may play a role in nerve regeneration. We report the fabrication and in vitro characterization of poly-lactic-co-glycolic acid (PLGA) microspheres encapsulating VEGF and the in vivo application of nerve conduits supplemented with VEGF-containing microspheres. PLGA microspheres containing VEGF were prepared by the double emulsion-solvent evaporation technique. This yielded 83.16% of microspheres with a diameter <53 μm. VEGF content measured by ELISA indicated 93.79±10.64% encapsulation efficiency. Release kinetics were characterized by an initial burst release of 67.6±8.25% within the first 24h, followed by consistent release of approximately 0.34% per day for 4 weeks. Bioactivity of the released VEGF was tested by human umbilical vein endothelial cell (HUVEC) proliferation assay. VEGF released at all time points enhanced HUVEC proliferation, confirming that VEGF retained its bioactivity throughout the 4 week time period. When the microsphere delivery system was placed in a biosynthetic nerve scaffold robust nerve regeneration was observed. This study established a novel system for controlled release of growth factors and enables in vivo studies of nerve conduits conditioned with this system.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019759      PMCID: PMC3972821          DOI: 10.1016/j.actbio.2011.10.001

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  42 in total

1.  In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres.

Authors:  Ralph de Boer; Andrew M Knight; Robert J Spinner; Martijn J A Malessy; Michael J Yaszemski; Anthony J Windebank
Journal:  J Biomed Mater Res A       Date:  2010-09-28       Impact factor: 4.396

2.  Revascularization of nerve grafts: an experimental study.

Authors:  G Penkert; W Bini; M Samii
Journal:  J Reconstr Microsurg       Date:  1988-07       Impact factor: 2.873

Review 3.  Mechanisms of polymer degradation and erosion.

Authors:  A Göpferich
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

4.  Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system.

Authors:  Jangwook Lee; Suk Ho Bhang; Honghyun Park; Byung-Soo Kim; Kuen Yong Lee
Journal:  Pharm Res       Date:  2010-03-10       Impact factor: 4.200

5.  Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth.

Authors:  Justin S Golub; Young-tae Kim; Craig L Duvall; Ravi V Bellamkonda; Divya Gupta; Angela S Lin; Daiana Weiss; W Robert Taylor; Robert E Guldberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

6.  Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge.

Authors:  A Eser Elcin; Y Murat Elcin
Journal:  Tissue Eng       Date:  2006-04

7.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

8.  Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods.

Authors:  M Iwata; Y Nakamura; J W McGinity
Journal:  J Microencapsul       Date:  1999 Jan-Feb       Impact factor: 3.142

9.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

10.  Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl.

Authors:  Duane T Birnbaum; Lisa Brannon-Peppas
Journal:  J Biomater Sci Polym Ed       Date:  2003       Impact factor: 3.517

View more
  24 in total

1.  Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules.

Authors:  Marie Francene A Cutiongco; Benjamin Kim Kiat Teo; Evelyn King Fai Yim
Journal:  J Vis Exp       Date:  2015-08-19       Impact factor: 1.355

2.  Injectable shear-thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors.

Authors:  Emine Alarçin; Tae Yong Lee; Sobha Karuthedom; Marzieh Mohammadi; Meadhbh A Brennan; Dong Hoon Lee; Alessandra Marrella; Jin Zhang; Denata Syla; Yu Shrike Zhang; Ali Khademhosseini; Hae Lin Jang
Journal:  Biomater Sci       Date:  2018-05-29       Impact factor: 6.843

3.  Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.

Authors:  Joanne O'Dwyer; Robert Murphy; Eimear B Dolan; Lenka Kovarova; Martin Pravda; Vladimir Velebny; Andreas Heise; Garry P Duffy; Sally Ann Cryan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

4.  Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres.

Authors:  Raymond C Pasek; Taylor E Kavanaugh; Craig L Duvall; Maureen A Gannon
Journal:  J Vis Exp       Date:  2016-11-05       Impact factor: 1.355

Review 5.  Strategies to improve regeneration of the soft palate muscles after cleft palate repair.

Authors:  Paola L Carvajal Monroy; Sander Grefte; Anne Marie Kuijpers-Jagtman; Frank A D T G Wagener; Johannes W Von den Hoff
Journal:  Tissue Eng Part B Rev       Date:  2012-07-19       Impact factor: 6.389

6.  Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures.

Authors:  Licheng Zhang; Lihai Zhang; Xia Lan; Meng Xu; Zhi Mao; Houchen Lv; Qi Yao; Peifu Tang
Journal:  J Mater Sci Mater Med       Date:  2014-01-17       Impact factor: 3.896

7.  Growth Factor-Loaded Microparticles for Tissue Engineering: The Discrepancies of In Vitro Characterization Assays.

Authors:  Nathalie Bock; Tim R Dargaville; Giles T S Kirby; Dietmar W Hutmacher; Maria A Woodruff
Journal:  Tissue Eng Part C Methods       Date:  2015-12-14       Impact factor: 3.056

8.  A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model.

Authors:  Ruth E Geuze; Lars F H Theyse; Diederik H R Kempen; Herman A W Hazewinkel; Helen Y A Kraak; F Cumhur Oner; Wouter J A Dhert; Jacqueline Alblas
Journal:  Tissue Eng Part A       Date:  2012-09-12       Impact factor: 3.845

9.  Vascularized bone transplant chimerism mediated by vascular endothelial growth factor.

Authors:  Wouter F Willems; Mikko Larsen; Patricia F Friedrich; Allen T Bishop
Journal:  Microsurgery       Date:  2014-07-30       Impact factor: 2.425

10.  [Advance of vascularization of tissue engineered peripheral nerve].

Authors:  Bin Zhao; Jianxiong Ma; Xinlong Ma
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.